Inbox Robot: Multiple Myeloma News http://www.inboxrobot.com/news/multiple-myeloma Constantly updated news and information about a variety of topics. Charles W. Marriott http://www.inboxrobot.com/news.php?fid=207376626 9 Jan 2009 20:29 GMT ... family and friends Thursday, Jan. 8, 2009, Charles Marriott ended his four-year battle with multiple myeloma at the age of 67. He was born on Aug. 24, 1941 in Stover, ... Nitric Oxide Monitoring of Little Benefit for Kids' Asthma http://www.inboxrobot.com/news.php?fid=207372885 9 Jan 2009 20:19 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ... Officials Still Seek Source of Salmonella Outbreak http://www.inboxrobot.com/news.php?fid=207372884 9 Jan 2009 20:19 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ... Childhood Leukemia Subtype Resists Treatment http://www.inboxrobot.com/news.php?fid=207360707 9 Jan 2009 18:57 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ... Clinical Trials Update: Jan. 9, 2009 http://www.inboxrobot.com/news.php?fid=207360704 9 Jan 2009 18:57 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ... Drug Pipeline Progress - January 1-9 http://www.inboxrobot.com/news.php?fid=207355217 9 Jan 2009 18:32 GMT ... Application. Initiates Phase1 Trial in patients with advanced solid tumors, Castleman's disease, or multiple myeloma, January 5, 2009 Company Comments: The primary endpoints of the oral dose escalating trial ... Parents Not Best Barometer of Kid's Eating, Exercise Habits http://www.inboxrobot.com/news.php?fid=207327802 9 Jan 2009 16:09 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ... Health Tip: See Your Doctor Before Pregnancy http://www.inboxrobot.com/news.php?fid=207327801 9 Jan 2009 16:09 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ... Sun Pharma wins FDA approval for four generic drugs http://www.inboxrobot.com/news.php?fid=207290745 9 Jan 2009 11:38 GMT ... of malignancy, paget's disease, osteolytic bone metastases of breast cancer and osteolytic lesions of multiple myeloma. Approval has been received for two strengths, 30mg vial and 90mg vial. In addition, ... What Does The Recession Mean For Pharmaceutical Prices: New Cutting Edge Information Report http://www.inboxrobot.com/news.php?fid=207276713 9 Jan 2009 10:12 GMT ... the seemingly recession-proof pharmaceutical industry cannot escape this type of scrutiny. For example, Celgene's multiple myeloma drug, , has drawn much criticism for its $260 per pill price tag, which ... The year in review http://www.inboxrobot.com/news.php?fid=207242197 9 Jan 2009 05:41 GMT ... Commission approvals, including: • Gilead’s Viread for hepatitis B • Celgene’s Thalidomide Pharmion for multiple myeloma • Astellas’s Mycamine for candidiasis • Boehringer Ingelheim’s Pradaxa for the prevention of blood ... Guidelines Unveiled for Treating Clogged Heart Arteries http://www.inboxrobot.com/news.php?fid=207221846 9 Jan 2009 01:59 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ... Drug Pipeline Progress - December 8-14 http://www.inboxrobot.com/news.php?fid=207201081 8 Jan 2009 23:31 GMT ... dose limiting toxicity of ENMD-2076 when administered orally once a day in patients with multiple myeloma who are refractory to other drug therapy. The study will also assess the safety, ... First Americans Arrived on 2 Separate Paths http://www.inboxrobot.com/news.php?fid=207163521 8 Jan 2009 19:31 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ... Clinical Trials Update: Jan. 8, 2009 http://www.inboxrobot.com/news.php?fid=207163519 8 Jan 2009 19:31 GMT ... the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma and multiple myeloma. Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPAR) activator indicated for use ...